Zoetis (NYSE:ZTS) Hits New 1-Year Low - Here's What Happened

Key Points

• Zoetis shares hit a new 52-week low, trading as low as $113.29 (last $113.48) on Friday with about 3.4 million shares changing hands.
• Analyst sentiment is mixed — the consensus is a Hold with an average target price of $152.91, while some firms cut targets (Piper Sandler to $135) and others upgraded ratings.
• The company beat quarterly EPS and revenue expectations, set FY 2026 guidance of $7.00–$7.10 EPS, and declared a quarterly dividend of $0.53 per share (≈1.9% yield).

Shares of Zoetis Inc. (NYSE:ZTS - Get Free Report) hit a new 52-week low on Friday . The stock traded as low as $113.29 and last traded at $113.4770, with a volume of 3404316 shares traded. The stock had previously closed at $116.63.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on the stock. Leerink Partners restated a "market perform" rating on shares of Zoetis in a report on Tuesday, March 10th. Wall Street Zen upgraded Zoetis from a "hold" rating to a "buy" rating in a research report on Saturday, February 21st. Weiss Ratings raised Zoetis from a "sell (d+)" rating to a "hold (c-)" rating in a research note on Thursday, March 12th. Piper Sandler reissued a "neutral" rating and set a $135.00 target price (down from $190.00) on shares of Zoetis in a research note on Thursday, January 22nd. Finally, William Blair reissued an "outperform" rating on shares of Zoetis in a research note on Monday, March 2nd. Six investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average target price of $152.91.

Zoetis Stock Performance

The company has a quick ratio of 1.94, a current ratio of 3.03 and a debt-to-equity ratio of 2.71. The company has a fifty day moving average price of $123.62 and a 200 day moving average price of $129.58. The stock has a market cap of $47.90 billion, a PE ratio of 18.85, a P/E/G ratio of 1.78 and a beta of 0.95.

Zoetis (NYSE:ZTS - Get Free Report) last posted its quarterly earnings results on Thursday, February 12th. The company reported $1.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.08. The business had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.36 billion. Zoetis had a return on equity of 62.02% and a net margin of 28.24%.Zoetis's revenue for the quarter was up 3.0% compared to the same quarter last year. During the same period last year, the company earned $1.40 EPS. Zoetis has set its FY 2026 guidance at 7.000-7.100 EPS. Analysts expect that Zoetis Inc. will post 6.07 earnings per share for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, June 2nd. Investors of record on Monday, April 20th will be issued a dividend of $0.53 per share. This represents a $2.12 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date is Monday, April 20th. Zoetis's payout ratio is currently 35.22%.

Institutional Trading of Zoetis

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Brighton Jones LLC grew its position in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company's stock worth $754,000 after buying an additional 2,978 shares during the period. Empowered Funds LLC raised its position in shares of Zoetis by 6.2% in the 1st quarter. Empowered Funds LLC now owns 11,293 shares of the company's stock worth $1,859,000 after purchasing an additional 657 shares during the last quarter. Intech Investment Management LLC raised its holdings in Zoetis by 17.2% in the 1st quarter. Intech Investment Management LLC now owns 8,347 shares of the company's stock worth $1,374,000 after acquiring an additional 1,224 shares during the last quarter. Sivia Capital Partners LLC lifted its position in Zoetis by 73.8% in the 2nd quarter. Sivia Capital Partners LLC now owns 3,348 shares of the company's stock valued at $522,000 after acquiring an additional 1,422 shares in the last quarter. Finally, Global Retirement Partners LLC bought a new position in shares of Zoetis during the second quarter valued at $301,000. Hedge funds and other institutional investors own 92.80% of the company's stock.

Zoetis Company Profile

Zoetis Inc NYSE: ZTS is a global animal health company that develops, manufactures and markets a broad portfolio of products and services for companion animals and livestock. The company's offerings include pharmaceuticals, vaccines and biologics, parasiticides and anti-infectives, as well as diagnostic instruments, consumables and laboratory testing services. Zoetis serves the veterinary community, livestock producers and other animal-health customers with products designed to prevent, detect and treat disease and to support animal productivity and welfare.

Zoetis traces its roots to the animal health business of Pfizer and became an independent, publicly traded company following a 2013 separation and initial public offering.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.